Ngl Fine-Chem Ltd. Share Price & Stock Analysis

Ngl Fine-Chem Ltd. (BSE: 524774) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹1,926 Cr, it ranks #1,265 by market cap among the 6,197 Indian listed companies on FinBizNet, and #38 of 86 in Medicinal Chemicals and Botanical Products. At ₹3,030.20 (as of 16 Nov 2026), the share price is 15.9% below its 52-week high of ₹3,602.00 and 138.4% above its 52-week low of ₹1,271.00. The share price is up 104.7% over one year and down 11.5% over three months.

Key Metrics

Current Price₹3,030.20
Market Cap₹1,926 Cr
BSE Code524774
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio40.1
Return on Equity15.74%
Return on Assets6.77%
52-Week Range₹1,271.00 – ₹3,602.00
1-Year Price Change+104.7%
3-Month Price Change-11.5%
Beta (1Y)0.37
Dividend Yield0.06%
HeadquartersMumbai, Maharashtra
Websitewww.nglfinechem.com

Latest Quarterly Results — Q2 FY27

Revenue₹159 Cr
Net Profit₹16 Cr
Net Margin10.2%
EPS (Basic)₹26.30
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Ngl Fine-Chem Ltd. Quarterly Revenue and Profit Trend

Ngl Fine-Chem Ltd. reported revenue of ₹159 Cr in Q2 FY27, up 32.0% from ₹120 Cr in Q2 FY26 and up 14.0% from ₹139 Cr in Q1 FY27. It posted a net profit of ₹16 Cr for the quarter, against a net profit of ₹10 Cr in Q2 FY26 (up 68.7%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹95 Cr (Q4 FY25) to ₹159 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹159 Cr₹16 Cr10.2%
Q1 FY27₹139 Cr₹18 Cr13.2%
Q4 FY26₹149 Cr₹13 Cr9.0%
Q3 FY26₹128 Cr₹16 Cr12.3%
Q2 FY26₹120 Cr₹10 Cr8.0%
Q1 FY26₹104 Cr₹9 Cr8.9%
Q4 FY25₹95 Cr₹1 Cr0.6%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 72.49% of Ngl Fine-Chem Ltd.'s shares as of Sept 2026, against 72.74% in Sept 2025 (−0.25 percentage points). Delivery averaged 40.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Ngl Fine-Chem Ltd.

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride t

Products and Services

1. Pharmaceuticals-This segment manufactures and exports veterinary and human active pharmaceutical ingredients, intermediates, and finished dosage forms.

Business Segments

1. Pharmaceuticals-100%

Ngl Fine-Chem Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Ngl Fine-Chem Ltd.₹1,926 Cr40.115.74%₹159 Cr+104.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Ngl Fine-Chem Ltd.?

Ngl Fine-Chem Ltd. is trading at ₹3,030.20, with a market capitalisation of ₹1,926 Cr.

Which sector does Ngl Fine-Chem Ltd. belong to?

Ngl Fine-Chem Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Ngl Fine-Chem Ltd.?

Ngl Fine-Chem Ltd. has a P/E of 40.1 and a return on equity of 15.74%.

What is the stock symbol of Ngl Fine-Chem Ltd.?

Ngl Fine-Chem Ltd. is listed on the BSE under the scrip code 524774.

How has Ngl Fine-Chem Ltd.'s share price moved over the past year?

Ngl Fine-Chem Ltd.'s share price is up 104.7% over one year and down 11.5% over three months. Its 52-week range is ₹1,271.00 to ₹3,602.00.

What were Ngl Fine-Chem Ltd.'s latest quarterly results?

In Q2 FY27, Ngl Fine-Chem Ltd. reported revenue of ₹159 Cr and net profit of ₹16 Cr, with basic EPS of ₹26.3 (consolidated, parsed from the company's exchange filing).

How have Ngl Fine-Chem Ltd.'s revenue and profit changed over the past year?

Ngl Fine-Chem Ltd. reported revenue of ₹159 Cr in Q2 FY27, up 32.0% from ₹120 Cr in Q2 FY26 and up 14.0% from ₹139 Cr in Q1 FY27.

What is the promoter holding in Ngl Fine-Chem Ltd.?

Promoters held 72.49% of Ngl Fine-Chem Ltd.'s shares as of Sept 2026, against 72.74% in Sept 2025 (−0.25 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.